Sort
130,381 grants matching “hiv”
Fluorescent nanofoldamers for multiplex flow cytometry
$825,109Christopher J Macnevin · Nirvana Sciences, Inc. · R44 · FY2022 · GM
AAV-mediated delivery of eCD4-Ig for prevention and treatment of perinatal HIV infection
$825,106Mauricio De Aguiar Martins · University Of Florida · R01 · FY2023 · HD
Determining the effects of broadly neutralizing antibodies at antiretroviral therapy initiation
$825,084Katharine June Bar · University Of Pennsylvania · R01 · FY2024 · AI
A nonhuman primate model of stem cell transplantation to understand determinants of post-transplant SIV clearance
$825,078Jonah B. Sacha · Oregon Health & Science University · R01 · FY2018 · AI
Virologic Correlates of Heterosexual Transmission
$825,072Eric Hunter · Emory University · R37 · FY2009 · AI
Combining Molecular Simulations and Biophysical Methods to Characterize Conformational Dynamics of the HIV-1 Envelope Glycoprotein
$825,050Cameron F Abrams · Drexel University · R01 · FY2023 · AI
University of California Global Health Institute Program for Fellows and Scholars
$825,036Craig R Cohen · University Of California, San Francisco · D43 · FY2021 · TW
MBRS-SCORE Program at UPR-Medical Sciences Campus
$825,000Walter I Silva · University Of Puerto Rico Med Sciences · S06 · FY2008 · GM
PROVISION OF ROUTINE HIV TESTING, COUNSELING, BASIC CARE & ANTIRETROVIRAL
$825,000Edward Ddumba · Makerere University College Of Health Sciences · U62 · FY2008 · PS
Clinical Trials Network: Greater New York Node
$825,000Edward V Nunes · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · U10 · FY2012 · DA
EXPANSION OF MALE CIRCUMCISION SERVICES TO PREVENT HIV IN BOTSWANA UNDER PEPFAR
$825,000Kelly Curran · Johns Hopkins University · U2G · FY2012 · PS
Neurofunctional Mechanisms of Changes in Cognition and Motor Function in Aging with HIV and Parkinson's Disease
$824,995Tilman Schulte · Sri International · R01 · FY2023 · AG
In vivo transformation of chimeric antigen receptor B cells for a functional cure of HIV
$824,985Michael R. Farzan · Boston Children'S Hospital · R01 · FY2024 · AI
Human Genes that Influence HIV-1 Replication, Pathogenesis, and Immunity in IVDUs
$824,937Jeremy Luban · Univ Of Massachusetts Med Sch Worcester · DP1 · FY2015 · DA
Mechanism of HIV Cell-Cell Transmission of Relevance to Substance Users
$824,937Heinrich Gottlinger · Univ Of Massachusetts Med Sch Worcester · DP1 · FY2015 · DA
A staged strategy for pathogen discovery
$824,927W. Ian Lipkin · Columbia University Health Sciences · U54 · FY2010 · AI
Glycan modification, CD4 independence, and Env immunogenicity
$824,905Shiu-Lok Hu · University Of Washington · R01 · FY2011 · AI
SV40-BASED COMBINATION GENETIC THERAPIES FOR HIV/SIV
$824,882Thomas Jefferson University · P01 · FY2000 · AI
Pharmacogenomics and Systems Pharmacology Approaches to Toxicity, Tolerability, and Comorbidities Associated with Modern Antiretroviral Therapies
$824,847Inga Peter · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · HG
Eliciting Broadly Neutralizing Antibody Responses against HIV-1 Fusion Peptide Epitope by AB Toxin B Subunit-Based Immunogens
$824,847Xiangpeng Kong · New York University School Of Medicine · R01 · FY2025 · AI
Effect of obesity on HIV pathogenesis, antiretroviral therapy, and metabolic comorbidities
$824,832Charles T Roberts · Oregon Health & Science University · R01 · FY2022 · DK
RAND COORDINATING CENTER: SEXUAL DIFFUSION OF HIV STUDY
$824,726Martin Yoneo Iguchi · Rand Corporation · U01 · FY2007 · DA
Effect of estrogen replacement on postmenopausal ART-associated comorbidity and viral latency
$824,709Paul Kievit · Oregon Health & Science University · R01 · FY2021 · AG
Mitigating the Outcomes Associated with the Injection Drug Use Epidemic in Southern Appalachia
$824,628William A Zule · Research Triangle Institute · UH3 · FY2019 · DA
Ultrasensitive Single-Genome Sequencing to Study HIV Transmission and Evolution
$824,615Mary Kearney · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA